The Food and Drug Administration approved GlaxoSmithKline's Shingrix vaccine to prevent painful shingles in people 50 and older. The Washington Post spoke with Edward Belongia, who chaired the shingles vaccine work group of the Advisory Committee on Immunization Practices. The CDC-funded Vaccine Safety Datalink is safety monitoring in near-real-time for this vaccine as it is rolled out. Q: You’re in the recommended age range to get a shingles vaccine. Read more:Expert panel recommends new, more effective shingles vaccine over existing oneRise in mumps outbreaks prompts U.S. panel to endorse 3rd vaccine doseFailure to vaccinate is probably the driver of U.S. measles outbreaks, report says

Source: Washington Post October 28, 2017 14:30 UTC